|
|
News Breaks
|
November 16, 2009
|
| 10:55 EDT |  | OSIP |
| theflyonthewall.com: | OSI Pharma says Tarceva to be reviewed by FDA | | OSI Pharmaceuticals announced that the Oncologic Drugs Advisory Committee) will review the use of Tarceva as a first-line maintenance therapy for patients with advanced non-small cell lung cancer who have not progressed following first-line treatment with platinum-based chemotherapy at its December 16, 2009 meeting. The ODAC panel is a committee of external experts, formed by the U.S. Food and Drug Administration, to advise the FDA in the evaluation of marketed and investigational drugs for use in the treatment of cancer. :theflyonthewall.com |
|
|
News For OSIP From The Last 14 Days Check below for free stories on OSIP the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
